California Neuroscience Research Medical Group, Inc
Sherman Oaks, California, United States
Doctor in Los Angeles, California
4835 Van Nuys Blvd # 104, Sherman Oaks, CA 91403
About California Neuroscience Research Medical Group, Inc
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
9
Naurex, Inc, an affiliate of Allergan plc
6
Hoffmann-La Roche
5
Biogen
4
Biohaven Pharmaceuticals, Inc.
4
Boehringer Ingelheim
4
Bristol-Myers Squibb
4
Eli Lilly and Company
4
Otsuka Pharmaceutical Development & Commercialization, Inc.
3
Allergan
2
Epix Pharmaceuticals, Inc.
2
Clinical Trials at California Neuroscience Research Medical Group, Inc
During the past decade, California Neuroscience Research Medical Group, Inc conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 29 clinical trials were completed, i.e. on
average, 82.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 17 clinical trials were completed. i.e. 113.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
2003-11-01
2007-10-01
Completed
1,306
Mifepristone as Adjunctive Therapy in Alzheimer's Disease
2003-04-01
2005-11-01
Terminated
160
A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
2008-04-01
Terminated
420
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
2008-05-01
Terminated
236
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
2009-05-01
2010-07-01
Completed
850
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
2009-02-01
2010-06-01
Completed
209
A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease
2009-05-01
2013-07-01
Terminated
263
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
2009-07-01
2012-06-01
Completed
716
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "California Neuroscience Research Medical Group, Inc" #1 sponsor was "Pfizer" with 9 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 6 trials
sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Biogen" with 4 trials sponsored and "Biohaven Pharmaceuticals, Inc."
with 4 trials sponsored. Other sponsors include 22 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "California Neuroscience Research Medical Group, Inc"
#1 collaborator was "Amgen" with 1 trials as a collaborator, "Banner Alzheimer's Institute" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Institute for the Study of Aging (ISOA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at California Neuroscience Research Medical Group, Inc
According to Clinical.Site data, the most researched conditions in "California Neuroscience Research Medical Group, Inc" are
"Alzheimer's Disease" (14 trials), "Alzheimer Disease" (8 trials), "Depressive Disorder, Major" (8 trials), "Major Depressive Disorder" (6 trials) and "Depression" (3 trials). Many other conditions were trialed in "California Neuroscience Research Medical Group, Inc" in a lesser frequency.
Clinical Trials Intervention Types at California Neuroscience Research Medical Group, Inc
Most popular intervention types in "California Neuroscience Research Medical Group, Inc" are "Drug" (55 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (33 trials), "Rapastinel" (6 trials), "Gantenerumab" (5 trials), "Aducanumab" (4 trials) and "ADT" (3 trials). Other intervention names were less common.
Clinical Trials Genders at California Neuroscience Research Medical Group, Inc
The vast majority of trials in "California Neuroscience Research Medical Group, Inc" are
55 trials for "All" genders.
Clinical Trials Status at California Neuroscience Research Medical Group, Inc
Currently, there are NaN active trials in "California Neuroscience Research Medical Group, Inc".
undefined are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 27 completed trials in California Neuroscience Research Medical Group, Inc,
undefined suspended trials,
and 19 terminated clinical trials to date.
Out of the total trials that were conducted in California Neuroscience Research Medical Group, Inc, 0 "Phase 1"
clinical trials were conducted, 20 "Phase 2" clinical
trials and 33 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 0 trials that are defined as “Not Applicable".